352 related articles for article (PubMed ID: 34896392)
1. Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases.
Murakami K; Izuo N; Bitan G
J Biol Chem; 2022 Jan; 298(1):101478. PubMed ID: 34896392
[TBL] [Abstract][Full Text] [Related]
2. Aptamer and its applications in neurodegenerative diseases.
Qu J; Yu S; Zheng Y; Zheng Y; Yang H; Zhang J
Cell Mol Life Sci; 2017 Feb; 74(4):683-695. PubMed ID: 27563707
[TBL] [Abstract][Full Text] [Related]
3. Nucleic acid aptamers for neurodegenerative diseases.
Bouvier-Müller A; Ducongé F
Biochimie; 2018 Feb; 145():73-83. PubMed ID: 29104136
[TBL] [Abstract][Full Text] [Related]
4. Advances in SELEX and application of aptamers in the central nervous system.
Yang Y; Yang D; Schluesener HJ; Zhang Z
Biomol Eng; 2007 Dec; 24(6):583-92. PubMed ID: 17681489
[TBL] [Abstract][Full Text] [Related]
5. Selection of aptamers for amyloid beta-protein, the causative agent of Alzheimer's disease.
Rahimi F; Bitan G
J Vis Exp; 2010 May; (39):. PubMed ID: 20616783
[TBL] [Abstract][Full Text] [Related]
6. SELEX methods on the road to protein targeting with nucleic acid aptamers.
Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
[TBL] [Abstract][Full Text] [Related]
7. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
Macedo B; Cordeiro Y
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
[TBL] [Abstract][Full Text] [Related]
8. Aptamers as innovative diagnostic and therapeutic agents in the central nervous system.
de Franciscis V; Esposito CL; Catuogno S; Cellai L; Cerchia L
CNS Neurol Disord Drug Targets; 2009 Nov; 8(5):393-401. PubMed ID: 19702567
[TBL] [Abstract][Full Text] [Related]
9. Aptamer Technology and Its Applications in Bone Diseases.
Liu X; Hu J; Ning Y; Xu H; Cai H; Yang A; Shi Z; Li Z
Cell Transplant; 2023; 32():9636897221144949. PubMed ID: 36591965
[TBL] [Abstract][Full Text] [Related]
10. Aptamers against cell surface receptors: selection, modification and application.
Wang J; Li G
Curr Med Chem; 2011; 18(27):4107-16. PubMed ID: 21838694
[TBL] [Abstract][Full Text] [Related]
11. Improved Anti-Prion Nucleic Acid Aptamers by Incorporation of Chemical Modifications.
Amato J; Mashima T; Kamatari YO; Kuwata K; Novellino E; Randazzo A; Giancola C; Katahira M; Pagano B
Nucleic Acid Ther; 2020 Dec; 30(6):414-421. PubMed ID: 32991255
[TBL] [Abstract][Full Text] [Related]
12. Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications.
Ni S; Zhuo Z; Pan Y; Yu Y; Li F; Liu J; Wang L; Wu X; Li D; Wan Y; Zhang L; Yang Z; Zhang BT; Lu A; Zhang G
ACS Appl Mater Interfaces; 2021 Mar; 13(8):9500-9519. PubMed ID: 32603135
[TBL] [Abstract][Full Text] [Related]
13. Aptamers as promising molecular recognition elements for diagnostics and therapeutics in the central nervous system.
McConnell EM; Holahan MR; DeRosa MC
Nucleic Acid Ther; 2014 Dec; 24(6):388-404. PubMed ID: 25296265
[TBL] [Abstract][Full Text] [Related]
14. Aptamers as Therapeutic Agents: Has the Initial Euphoria Subsided?
Haßel SK; Mayer G
Mol Diagn Ther; 2019 Jun; 23(3):301-309. PubMed ID: 31037641
[TBL] [Abstract][Full Text] [Related]
15. Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications.
Xiao X; Li H; Zhao L; Zhang Y; Liu Z
Biomed Pharmacother; 2021 Nov; 143():112232. PubMed ID: 34649356
[TBL] [Abstract][Full Text] [Related]
16. Chimeric aptamers in cancer cell-targeted drug delivery.
Kanwar JR; Roy K; Kanwar RK
Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
[TBL] [Abstract][Full Text] [Related]
17. Strategies to manipulate the performance of aptamers in SELEX, post-SELEX and microenvironment.
Qi S; Duan N; Khan IM; Dong X; Zhang Y; Wu S; Wang Z
Biotechnol Adv; 2022; 55():107902. PubMed ID: 35026382
[TBL] [Abstract][Full Text] [Related]
18. Advancements in Aptamer Discovery Technologies.
Gotrik MR; Feagin TA; Csordas AT; Nakamoto MA; Soh HT
Acc Chem Res; 2016 Sep; 49(9):1903-10. PubMed ID: 27526193
[TBL] [Abstract][Full Text] [Related]
19. DNA and RNA aptamers as modulators of protein function.
Ulrich H
Med Chem; 2005 Mar; 1(2):199-208. PubMed ID: 16787315
[TBL] [Abstract][Full Text] [Related]
20. The development and testing of aptamers for cancer.
Barbas AS; White RR
Curr Opin Investig Drugs; 2009 Jun; 10(6):572-8. PubMed ID: 19513946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
